Health News Releases

  • Today May 17
July 25, 2019 14:16
Multi-Lactobacillus BARU Developed by GSL-BIO Showed Excellent Effects on Environmental Improvement
BARU, the multi-lactobacillus developed by a Korean microorganism company GSL-BIO, has been proven to improve water quality drastically. BARU is a multi-lactobacillus made of seed microorganism tha
July 23, 2019 16:09
Study Investigates the Ability of Continuous Noninvasive Hemoglobin Monitoring with Masimo SpHb® to Reflect Acute Hemodilution During Incremental Fluid Administration
Masimo (NASDAQ: MASI) announced today that in a study recently published in Anesthesia & Analgesia, researchers evaluated the ability of noninvasive and continuous hemoglobin monitoring with Masimo Sp
July 22, 2019 14:43
FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with or
July 22, 2019 14:35
Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Crohn's Disease
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced top-line results from the VISIBLE 2 clinical trial evaluating the efficacy and safety of an investigational subcuta
July 19, 2019 15:22
Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics
Boehringer Ingelheim and Bridge Biotherapeutics Inc. today announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge Biotherapeutics’s autotaxi
July 17, 2019 13:13
St. Luke’s Medical Center Selects Allscripts Sunrise™
St. Luke’s Medical Center, located in the Philippines, has selected Allscripts (NASDAQ: MDRX) Sunrise™ Acute Care as its electronic health record (EHR) to achieve the goal of standardization across it
July 16, 2019 14:20
Gemtech Targets the Asian Market with Its Medical Devices and Coating and Plating, and Special Spray Products
Gemtech Co., Ltd. is enhancing its R&D and marketing capability to expand the business into the Asian market with its medical devices, coating and plating facility, and special spray products. Gemt
July 16, 2019 14:15
SpeeDx Receives Clearance from Health Canada for ResistancePlus® MG Test
SpeeDx Pty. Ltd. today announced ResistancePlus® MG has been cleared by Health Canada and is now available for sale across all Canadian provinces (not currently available in the U.S.). The molecular d
July 16, 2019 14:08
ResMed Inc. Completes $500M Private Placement Debt Offering
ResMed Inc. (NYSE: RMD, ASX: RMD) announced today the successful pricing and closing of a private placement offering of $250,000,000 principal amount 3.24% senior notes due July 10, 2026, and $250,000
July 16, 2019 13:03
Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform
Boehringer Ingelheim today announced its acquisition of all shares of AMAL Therapeutics SA, a private Swiss biotechnology company focused on cancer immunotherapy and advancing first-in-class therapeut
July 16, 2019 09:50
New Study Investigates the Utility of Masimo ORi™, Oxygen Reserve Index, As an Indicator to Avoid Hyperoxia During General Anesthesia
Masimo (NASDAQ: MASI) announced today that in a study recently published in the Journal of Clinical Monitoring and Computing, researchers investigated the ability of Masimo ORi™ (Oxygen Reserve Index)
July 11, 2019 14:38
Takeda Continues Ongoing Inclusion in the FTSE4Good Developed Index & MSCI ESG Leaders Index
Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502/NYSE:TAK) today announced that it has been selected for the 15th consecutive year by the FTSE4Good Developed Index, one of the world’s prem
July 11, 2019 13:32
The Lancet Publishes: More Than 936 Million Have Obstructive Sleep Apnea Worldwide
More than 936 million people have obstructive sleep apnea - the disease’s first prevalence update in more than a decade - according to The Lancet Respiratory Medicine, the world’s leading journal in i
July 11, 2019 10:32
GVK BIO Announces Appointment of Robert R. Ruffolo, Ph.D., to its Board of Directors
GVK BIO is pleased to announce the appointment of Dr. Robert (Bob) R. Ruffolo, to its Board of Directors. “On behalf of GVK BIO and its Board of Directors, I am pleased to welcome Dr. Robert Ruffol
July 10, 2019 17:08
Morinaga Milk’s Probiotic Bifidobacterium longum BB536 Achieves Self-Affirmed GRAS for Infants in Celebration of Its 50th Anniversary
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Morinaga Bifidobacterium longum BB536 has received self-affirmed GRAS
Nepal: Due to postpartum haemorrhage (PPH), Tulasi was rushed to have emergency blood transfusions a
July 10, 2019 10:35
Heat-stable carbetocin has been added to the WHO Essential Medicines List for the prevention of excessive bleeding after childbirth
Ferring Pharmaceuticals today welcomes the World Health Organization’s (WHO) addition of heat-stable carbetocin to the WHO Model List of Essential Medicines (EML) of uterotonics for the prevention of
July 09, 2019 17:29
Dabigatran’s safety and efficacy established for management of VTE in children
Boehringer Ingelheim today announced results from two paediatric studies of dabigatran etexilate, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress i
July 09, 2019 13:29
Aptorum Group’s subsidiary Smart Pharma announces Smart Pharma token (SMPT) to be listed on IDAX and LATOKEN
Aptorum Group Limited (Nasdaq: APM) subsidiary Smart Pharmaceutical is excited to announce that the Smart Pharma Token (“SMPT token”), is to be available for trading on IDAX (https://www.idax.pro/) an
July 09, 2019 09:44
Octapharma Present New Data on the Benefits Of Nuwiq® In Patients With Haemophilia A at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress
Octapharma announced today that new data on the benefits of Nuwiq® in patients with haemophilia A were presented during a scientific symposium at the 27th International Society on Thrombosis and Haemo
July 08, 2019 16:35
Takeda Unveil New Data from the PROPEL Study at ISTH 2019, Reinforcing the Potential Benefit for Personalized Prophylaxis with ADYNOVATE in Severe Hemophilia A
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”), R&D-driven, global biopharmaceutical company with a leadership position in rare diseases, has today announced updated results from
July 08, 2019 10:56
Mary Kay Inc. Sponsors University of the Philippines Medical Alumni Society of America 34th Annual Grand Convention
Mary Kay Inc., a leading skincare innovator, continued its decades-long commitment to science through its sponsorship of the University of the Philippines Medical Alumni Society of America (UPMASA) 34
July 08, 2019 10:09
Octapharma communicates an update on the development of SubQ-8, a novel subcutaneous recombinant FVIII, at ISTH 2019
Octapharma announced that an update on the clinical development plan and pre-clinical data with SubQ-8 were presented today in a scientific symposium at the 27th International Society on Thrombosis an
July 05, 2019 09:37
L’Oréal Rewards Social Initiatives Led by Dermatologists at World Congress of Dermatology in Milan
In partnership with the International League of Dermatological Societies (ILDS) and the 24th World Congress of Dermatology (WCD), L’Oréal announced the laureates of the third International Awards for
July 04, 2019 10:26
Takeda to Demonstrate Global Leadership in Hematology at ISTH 2019
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”), the global biotechnology leader in rare diseases, will present research covering a broad range of rare bleeding disorders at the 2
July 03, 2019 10:20
Octapharma to Present New Data on Management of People with Haemophilia A or von Willebrand Disease at ISTH 2019
New scientific data on Octapharma’s Haematology portfolio will be presented at the upcoming 27th Congress of the International Society on Thrombosis and Haemostasis (ISTH), taking place in Melbourne,
25 per page50 per page75 per page100 per page